Kerim, you say "Admedus is no longer a speculative stock, they have actual real products."
Firstly they have two clinical trials in progress (HSV and HPV) with the final results unknown, in other words people "speculate" on the outcome.
Secondly the company is applying its ADAPT technologies to other areas with investors "speculating" on the overall clinical outcomes and sales potential.
Thirdly the company is loss making and investors are "speculating" that in the future the company will turn a profit.
A non-speculative stock doesn't trade at 12 cents.
Kerim, you say "Admedus is no longer a speculative stock, they...
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.68 |
Change
0.680(4.53%) |
Mkt cap ! $331.4M | |||
| Open | High | Low | Value | Volume |
| $14.90 | $15.75 | $14.85 | $431.9K | 28.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $15.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.95 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |